跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hyoscimide - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hyoscimide
Approved
STANDARD
Hyoscimide
Inga Laboratories P. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b6729228117731b1
Company
Inga Laboratories P. Ltd.
Type
Standard
Approval Details
Approval Id
b6729228117731b1
Drug Approval Philippines Name
Hyoscimide
Product Name
Hyoscimide
Registration Number
DRP-6548-02
Brand Name
Hyoscimide
Generic Name
Hyoscine Butylbromide
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Inga Laboratories P. Ltd.
Importer
Ambica International Corporation
Distributor
Ambitech Biopharmaceuticals Inc
Issuance Date
29 April 2022
Expiry Date
08 March 2026
Pharmacologic Category
Antispasmodic
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b6729228117731b1
Type
Standard
Back to Philippines FDA Approvals